Literature DB >> 18066623

The economic impact of obstructive sleep apnea.

Nayef AlGhanim1, Vikram R Comondore, John Fleetham, Carlo A Marra, Najib T Ayas.   

Abstract

Untreated obstructive sleep apnea (OSA) increases healthcare utilization and is associated with reduced work performance and occupational injuries. The economic burden related to untreated OSA is substantial, accounting for billions of dollars per year. Furthermore, therapy of OSA is an extremely cost-efficient use of healthcare resources, comparing highly favorably with other commonly funded medical therapies. Governments, transportation agencies, industry, and insurance companies need to be better informed concerning the economic impact of untreated OSA and the benefits of therapy.

Entities:  

Mesh：

Year:  2007        PMID： 18066623     DOI： 10.1007/s00408-007-9055-5

Source DB:  PubMed          Journal:  Lung        ISSN： 0341-2040            Impact factor:   2.584


  48 in total

1.  Role of snoring and daytime sleepiness in occupational accidents.

Authors:  E Lindberg; N Carter; T Gislason; C Janson
Journal:  Am J Respir Crit Care Med       Date:  2001-12-01       Impact factor: 21.405

Review 2.  The burden of asthma with specific reference to the United States.

Authors:  Richard Beasley
Journal:  J Allergy Clin Immunol       Date:  2002-05       Impact factor: 10.793

3.  Improvement of subjective work performance among obstructive sleep apnea patients after treatment with continuous positive airway pressure.

Authors:  J Ulfberg; R Jonsson; C Edling
Journal:  Psychiatry Clin Neurosci       Date:  1999-12       Impact factor: 5.188

4.  Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis.

Authors:  Sanjay R Patel; David P White; Atul Malhotra; Michael L Stanchina; Najib T Ayas
Journal:  Arch Intern Med       Date:  2003-03-10

5.  Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial.

Authors:  C Jenkinson; R J Davies; R Mullins; J R Stradling
Journal:  Lancet       Date:  1999-06-19       Impact factor: 79.321

6.  The association between sleep apnea and the risk of traffic accidents. Cooperative Group Burgos-Santander.

Authors:  J Terán-Santos; A Jiménez-Gómez; J Cordero-Guevara
Journal:  N Engl J Med       Date:  1999-03-18       Impact factor: 91.245

7.  Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics.

Authors:  L A Prosser; A A Stinnett; P A Goldman; L W Williams; M G Hunink; L Goldman; M C Weinstein
Journal:  Ann Intern Med       Date:  2000-05-16       Impact factor: 25.391

Review 8.  Cost-effectiveness of anti-tumor necrosis factor agents.

Authors:  J B Wong
Journal:  Clin Exp Rheumatol       Date:  2004 Sep-Oct       Impact factor: 4.473

Review 9.  Obstructive sleep apnea: implications for cardiac and vascular disease.

Authors:  Abu S M Shamsuzzaman; Bernard J Gersh; Virend K Somers
Journal:  JAMA       Date:  2003-10-08       Impact factor: 56.272

10.  Fatal occupational injuries--United States, 2005.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2007-04-06       Impact factor: 17.586
View more
  78 in total

1.  Age- and gender-related characteristics of obstructive sleep apnea.

Authors:  Itay E Gabbay; Peretz Lavie
Journal:  Sleep Breath       Date:  2011-04-16       Impact factor: 2.816

Review 2.  Sleep-disordered breathing and COPD: the overlap syndrome.

Authors:  Robert L Owens; Atul Malhotra
Journal:  Respir Care       Date:  2010-10       Impact factor: 2.258

3.  Long-term effectiveness of oral appliance versus CPAP therapy and the emerging importance of understanding patient preferences.

Authors:  Fernanda R Almeida; Nick Bansback
Journal:  Sleep       Date:  2013-09-01       Impact factor: 5.849

4.  Executive dysfunction in OSA before and after treatment: a meta-analysis.

Authors:  Michelle Olaithe; Romola S Bucks
Journal:  Sleep       Date:  2013-09-01       Impact factor: 5.849

5.  The impact of CPAP on cardiovascular biomarkers in minimally symptomatic patients with obstructive sleep apnea: a pilot feasibility randomized crossover trial.

Authors:  Vikram R Comondore; Rupi Cheema; Joel Fox; Arsalan Butt; G B John Mancini; John A Fleetham; C Frank Ryan; Sammy Chan; Najib T Ayas
Journal:  Lung       Date:  2008-09-16       Impact factor: 2.584

6.  Hypercoagulability: another potential mechanism of obstructive sleep apnea-related cardiovascular disease?

Authors:  Nabil M Al Lawati; Najib T Ayas
Journal:  Lung       Date:  2008-04-22       Impact factor: 2.584

Review 7.  Diagnostic accuracy of level 3 portable sleep tests versus level 1 polysomnography for sleep-disordered breathing: a systematic review and meta-analysis.

Authors:  Mohamed El Shayeb; Leigh-Ann Topfer; Tania Stafinski; Lawrence Pawluk; Devidas Menon
Journal:  CMAJ       Date:  2013-11-11       Impact factor: 8.262

8.  Multidisciplinary sleep centers: strategies to improve care of sleep disorders patients.

Authors:  Anita Valanju Shelgikar; Jeffrey S Durmer; Karen E Joynt; Eric J Olson; Heidi Riney; Paul Valentine
Journal:  J Clin Sleep Med       Date:  2014-06-15       Impact factor: 4.062

Review 9.  Diabetes, sleep apnea, obesity and cardiovascular disease: Why not address them together?

Authors:  Salim R Surani
Journal:  World J Diabetes       Date:  2014-06-15

Review 10.  Risk of Occupational Accidents in Workers with Obstructive Sleep Apnea: Systematic Review and Meta-analysis.

Authors:  Sergio Garbarino; Ottavia Guglielmi; Antonio Sanna; Gian Luigi Mancardi; Nicola Magnavita
Journal:  Sleep       Date:  2016-06-01       Impact factor: 5.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.